Ryan A Doan

Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice.

J. Milbrandt, A. Diantonio, S. Geisler, 2016, Brain : a journal of neurology.

Gene therapy targeting SARM1 blocks pathological axon degeneration in mice

J. Milbrandt, A. Diantonio, S. Geisler, 2019, The Journal of experimental medicine.

Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.

J. Milbrandt, A. Höke, A. Diantonio, 2019, JCI insight.

TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance

J. Milbrandt, C. Weihl, A. Diantonio, 2016, The Journal of Neuroscience.